About Rion
Rion's acoustics and vibration technologies support businesses and lifestyles in various fields.
Financial Highlights
Transition of consolidated financial results of the past 5 years
* Fiscal years ended March 31.
1. Consolidated management performance
| FY ended Mar. 31, 2021 |
FY ended Mar. 31, 2022 |
FY ended Mar. 31, 2023 |
FY ended Mar. 31, 2024 |
FY ended Mar. 31, 2025 |
||
|---|---|---|---|---|---|---|
| Net sales (¥ Million) | 20,466 | 22,635 | 23,868 | 25,726 | 27,877 | |
| Particle Counter Division (¥ Million) | 5,172 | 6,265 | 6,619 | 7,559 | 9,546 | |
| Medical Instrument Division (¥ Million) | 11,081 | 11,707 | 12,175 | 12,749 | 12,530 | |
| Environmental Instrument Division (¥ Million) | 4,212 | 4,662 | 5,073 | 5,417 | 5,800 | |
| Operating income (¥ Million) | 2,220 | 3,104 | 2,844 | 3,474 | 4,033 | |
| Particle Counter Division (¥ Million) | 1,334 | 1,725 | 1,538 | 2,062 | 2,779 | |
| Medical Instrument Division (¥ Million) | 409 | 805 | 1,005 | 1,308 | 1,090 | |
| Environmental Instrument Division (¥ Million) | 476 | 573 | 299 | 104 | 168 | |
| Ordinary income (¥ Million) | 2,297 | 3,212 | 3,007 | 3,562 | 4,106 | |
| Net income (¥ Million) | 1,636 | 2,229 | 1,799 | 2,652 | 2,859 | |
| Net income per share (J¥) | 133.27 | 181.41 | 146.33 | 215.51 | 232.19 | |
| Return on equity (%) | 7.1 | 9.1 | 6.9 | 9.5 | 9.4 | |
| Return on assets (%) | 7.6 | 10.1 | 8.9 | 9.9 | 10.8 | |
| Operating margin (%) | 10.9 | 13.7 | 11.9 | 13.5 | 14.5 | |
2. Consolidated financial position
| FY ended Mar. 31, 2021 |
FY ended Mar. 31, 2022 |
FY ended Mar. 31, 2023 |
FY ended Mar. 31, 2024 |
FY ended Mar. 31, 2025 |
|
|---|---|---|---|---|---|
| Total assets (¥ Million) | 30,683 | 33,157 | 34,557 | 37,140 | 39,132 |
| Net assets (¥ Million) | 23,726 | 25,289 | 26,612 | 29,211 | 31,435 |
| Equity ratio (%) | 77.3 | 76.3 | 77.0 | 78.7 | 80.3 |
| Book-value per share (¥) | 1,931.15 | 2,057.40 | 2,163.30 | 2,372.88 | 2,551.75 |
3. Consolidated condition of cash flows
(¥ Million)
| FY ended Mar. 31, 2021 |
FY ended Mar. 31, 2022 |
FY ended Mar. 31, 2023 |
FY ended Mar. 31, 2024 |
FY ended Mar. 31, 2025 |
|
|---|---|---|---|---|---|
| Cash flows from operating activities | 2,064 | 2,841 | 1,783 | 2,857 | 3,437 |
| Cash flows from investing activities | ∆1,137 | ∆951 | ∆3,246 | ∆2,652 | ∆1,685 |
| Cash flows from financing activities | ∆566 | ∆541 | ∆577 | ∆565 | ∆748 |
| Cash and cash equivalents at end of year | 5,826 | 7,181 | 5,206 | 4,860 | 5,848 |